OR WAIT null SECS
Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
April 07, 2020
Characterizing and controlling protein aggregation is vital to ensure safety and efficacy of a biopharmaceutical product. In this interview, important aspects of protein aggregation and the tools available to address this issue are discussed.
April 02, 2020
As COVID-19 rapidly spreads, the bio/pharma industry is committing significant efforts to fast track development of therapies.
Considering the potential interaction of a drug with the delivery device early on in in development is integral to achieving the best combination.
The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery.
April 01, 2020
Understanding formulation properties early in development can prevent some costly issues later on.
OSD forms are popular within the industry due to the various advantages they offer, but there are specific considerations required to get the best OSD form possible.